Active Ingredient |
Commercial Name |
Status |
Amlodipine maleate |
Novacot Tab. |
end item marketing after materials synthesizing |
Aceclofenac |
Cenital Tab. |
end item marketing after materials synthesizing |
Alibendol |
Alione Tab. |
end item marketing after materials synthesizing |
Atracurium besylate |
Atra Inj. 2.5ml |
end item marketing after materials synthesizing |
Cimetropium bromide |
Alpit Inj. |
end item marketing after materials synthesizing |
Carvedilol |
Cavetrend Tab. |
end item marketing after materials synthesizing |
Dexibuprofen |
Dexafen Tab. |
end item marketing after materials synthesizing |
Felodipine |
Stapin ER Tab. |
end item marketing after materials synthesizing, |
Finasteride |
Procare Tab. |
end item marketing after materials synthesizing |
fentanyl |
Fentas Patch |
end item marketing after developing patch product |
Flecainide Acetetate |
Fulcard Tab. 50mg |
end item marketing after materials synthesizing |
Glimepiride |
Dairid Tab. |
end item marketing after materials synthesizing |
Gabapentine |
New-gaba Cap. |
end item marketing after materials synthesizing |
Ketorolac tromethamine |
Keromin Inj. |
end item marketing after materials synthesizing |
Loxoprofen sodium |
Luckyfen Tab. |
end item marketing after materials synthesizing |
Levosulpiride |
Levomin Tab. |
end item marketing after materials synthesizing |
Meloxicam |
Memobic Cap. |
end item marketing after materials synthesizing |
Ondansetron HCl |
Hana Ondansetron Tab. |
end item marketing after materials synthesizing |
Phendimetrazine¤ýL-tartarte |
Fenslim Tab. |
end item marketing after materials synthesizing |
Propopol |
Anepol |
end item marketing after developing emulsion |
Simvastatine |
Simcol Tab. |
end item marketing after materials synthesizing |
Tiropramide HCl |
Tipas Tab. |
end item marketing after materials synthesizing |
Triflusal |
Tigrin Cap. |
end item marketing after materials synthesizing |
Warfarine sodium |
Kufarin Tab. |
end item marketing after materials synthesizing |